EC Healthcare (2138.HK)
HKD 0.64
(1.59%)
HKD 0.64
(1.59%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 704.74 Million HKD | 4.46% |
| 2022 | 674.66 Million HKD | -10.41% |
| 2021 | 753.04 Million HKD | 44.97% |
| 2020 | 519.46 Million HKD | -20.07% |
| 2019 | 649.93 Million HKD | -33.1% |
| 2018 | 971.49 Million HKD | 37.4% |
| 2017 | 707.08 Million HKD | 44.57% |
| 2016 | 489.07 Million HKD | 24.73% |
| 2015 | 392.09 Million HKD | 8.7% |
| 2014 | 360.73 Million HKD | 48.55% |
| 2013 | 242.83 Million HKD | 282.35% |
| 2012 | 63.51 Million HKD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q4 | 666.23 Million HKD | 85.41% |
| 2023 Q2 | 359.32 Million HKD | 18.48% |
| 2023 FY | 704.74 Million HKD | 4.46% |
| 2022 FY | 674.66 Million HKD | -10.41% |
| 2022 Q4 | 303.26 Million HKD | -18.34% |
| 2022 Q2 | 371.39 Million HKD | 25.2% |
| 2021 Q2 | 456.4 Million HKD | 49.71% |
| 2021 Q4 | 296.64 Million HKD | -35.0% |
| 2021 FY | 753.04 Million HKD | 44.97% |
| 2020 FY | 519.46 Million HKD | -20.07% |
| 2020 Q4 | 304.86 Million HKD | 51.44% |
| 2020 Q2 | 201.31 Million HKD | -5.77% |
| 2019 Q4 | 213.63 Million HKD | -51.04% |
| 2019 Q2 | 436.3 Million HKD | -7.56% |
| 2019 FY | 649.93 Million HKD | -33.1% |
| 2018 FY | 971.49 Million HKD | 37.4% |
| 2018 Q2 | 499.49 Million HKD | 30.84% |
| 2018 Q4 | 472 Million HKD | -5.5% |
| 2017 Q4 | 381.77 Million HKD | 17.36% |
| 2017 FY | 707.08 Million HKD | 44.57% |
| 2017 Q2 | 325.3 Million HKD | 13.96% |
| 2016 FY | 489.07 Million HKD | 24.73% |
| 2016 Q2 | 203.61 Million HKD | 4.39% |
| 2016 Q4 | 285.46 Million HKD | 40.2% |
| 2015 FY | 392.09 Million HKD | 8.7% |
| 2015 Q4 | 195.04 Million HKD | -1.02% |
| 2015 Q2 | 197.05 Million HKD | -3.7% |
| 2014 Q2 | 156.11 Million HKD | 0.0% |
| 2014 FY | 360.73 Million HKD | 48.55% |
| 2014 Q4 | 204.61 Million HKD | 31.06% |
| 2013 FY | 242.83 Million HKD | 282.35% |
| 2012 FY | 63.51 Million HKD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 200.34 Million HKD | -251.764% |
| Innovative Pharmaceutical Biotech Limited | 840 Thousand HKD | -83797.738% |
| China Overseas Nuoxin International Holdings Limited | 35.69 Million HKD | -1874.562% |
| Prosperous Future Holdings Limited | 71.05 Million HKD | -891.836% |
| Huasheng International Holding Limited | 154.45 Million HKD | -356.27% |
| Fourace Industries Group Holdings Limited | 95.5 Million HKD | -637.926% |
| Evergreen Products Group Limited | 233.23 Million HKD | -202.162% |
| Ming Fai International Holdings Limited | 488.74 Million HKD | -44.193% |
| Blue Moon Group Holdings Limited | 4.35 Billion HKD | 83.828% |
| SuperRobotics Holdings Limited | 7.28 Million HKD | -9579.179% |
| Takbo Group Holdings Limited | 75.4 Million HKD | -834.608% |
| Hyfusin Group Holdings Limited | 335.54 Million HKD | -110.031% |